It was recently shown, in another preclinical study, that blocking BMP9, using a neutralizing anti-BMP9 antibody, significantly reduced renal tumor growth and reduced tumor vascular permeability [48] suggesting potential differences between different tumor types. This evidence concerns the gene GDF2 and neoplasm.